Kisqali Is Indicated For The Treatment Of Adult Patients With Hormone Receptor (Hr)-Positive, Human Epidermal Growth Factor Receptor 2 (Her2)-Negative Advanced Or Metastatic Breast Cancer In Combination With: An Aromatase Inhibitor As Initial Endocrine-Based Therapy; Or Fulvestrant As Initial Endocrine-Based Therapy Or Following Disease Progression On Endocrine Therapy In Postmenopausal Women Or In Men.
Lynparza Is A Poly (Adp-Ribose) Polymerase (Parp) Inhibitor Indicated: First-Line Maintenance Brcam Advanced Ovarian Cancer For The Maintenance Treatment Of Adult Patients With Deleterious Or Suspected Deleterious Germline Or Somatic Brca-Mutated (Gbrcam Or Sbrcam) Advanced Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer Who Are In Complete Or Partial Response To First-Line Platinum-Based Chemotherapy. Select Patients For Therapy Based On An Fda-Approved Companion Diagnos
Auvelity Is Indicated For The Treatment Of Major Depressive Disorder (Mdd) In Adults.
Brukinsa® (Zanubrutinib) Is A Kinase Inhibitor Indicated For The Treatment Of Adult Patients With: Waldenström’S Macroglobulinemia (Wm). Mantle Cell Lymphoma (Mcl) Who Have Received At Least One Prior Therapy. Relapsed Or Refractory Marginal Zone Lymphoma (Mzl) Who Have Received At Least One Anti-Cd20-Based Regimen.
Calquence Is A Bruton Tyrosine Kinase (Btk) Inhibitor Indicated For The Treatment Of Adult Patients With Mantle Cell Lymphoma (Mcl) Who Have Received At Least One Prior Therapy.
Jaypirca Is A Kinase Inhibitor Indicated For The Treatment Of Adult Patients With Relapsed Or Refractory (R/R) Mantle Cell Lymphoma (Mcl) After At Least Two Lines Of Systemic Therapy, Including A Btk Inhibitor.
Dupixent Is Indicated As An Add-On Maintenance Treatment In Patients With Moderate-To-Severe Asthma Aged 12 Years And Older With An Eosinophilic Phenotype Or With Oral Corticosteroid Dependent Asthma. Limitation Of Use: Dupixent Is Not Indicated For The Relief Of Acute Bronchospasm Or Status Asthmaticus.
Verzenio® Is A Kinase Inhibitor Indicated: • In Combination With An Aromatase Inhibitor As Initial Endocrine-Based Therapy For The Treatment Of Postmenopausal Women With Hormone Receptor (Hr)-Positive, Human Epidermal Growth Factor Receptor 2 (Her2)-Negative Advanced Or Metastatic Breast Cancer.
Qvar Redihaler Is A Corticosteroid Indicated For Maintenance Treatment Of Asthma As Prophylactic Therapy In Adults And Pediatric Patients 4 Years Of Age And Older.
Abilify Maintena Is An Atypical Antipsychotic Indicated For: • Treatment Of Schizophrenia In Adults • Maintenance Monotherapy Treatment Of Bipolar I Disorder In Adults
Rozlytrek Is Indicated For The Treatment Of Adult Patients With Metastatic Non-Small Cell Lung Cancer (Nsclc) Whose Tumors Are Ros1-Positive.
Olumiant (Baricitinib) Is A Prescription Medicine Called A Janus Kinase (Jak) Inhibitor Used To Treat Adults With Alopecia Areata
Leqvio (Inclisiran) Injection Is Indicated As An Adjunct To Diet And Maximally Tolerated Statin Therapy For The Treatment Of Adults With Clinical Atherosclerotic Cardiovascular Disease (Ascvd) Or Heterozygous Familial Hypercholesterolemia (Hefh) Who Require Additional Lowering Of Low-Density Lipoprotein Cholesterol (Ldl-C). Limitations Of Use: The Effect Of Leqvio On Cardiovascular Morbidity And Mortality Has Not Been Determined.
Privigen Is Indicated For The Treatment Of Chronic Inflammatory Demyelinating Polyneuropathy (Cidp) In Adults. Limitation Of Use: Maintenance Therapy In Cidp Has Not Been Studied For Periods Longer Than 6 Months. Individualize Duration Of Treatment Beyond 6 Months Based On Patient Response.
Nucala Is An Interleukin-5 (Il-5) Antagonist Monoclonal Antibody (Igg1 Kappa) Indicated For: • Add-On Maintenance Treatment Of Adult And Pediatric Patients Aged 6 Years And Older With Severe Asthma And With An Eosinophilic Phenotype. • Add-On Maintenance Treatment Of Adult Patients 18 Years And Older With Chronic Rhinosinusitis With Nasal Polyps (Crswnp). • The Treatment Of Adult Patients With Eosinophilic Granulomatosis With Polyangiitis (Egpa). • The Treatment Of Adult And Pediatric Pat
Zeposia® (Ozanimod) Is Indicated For The Treatment Of Moderately To Severely Active Ulcerative Colitis (Uc) In Adults.
Tibsovo Is An Isocitrate Dehydrogenase-1 (Idh1) Inhibitor Indicated For The Treatment Of Adult Patients With A Susceptible Idh1 Mutation As Detected By An Fda-Approved Test With: Acute Myeloid Leukemia (Aml) Newly-Diagnosed Aml Who Are = 75 Years Old Or Who Have Comorbidities That Preclude Use Of Intensive Induction Chemotherapy. Relapsed Or Refractory Aml. Locally Advanced Or Metastatic Cholangiocarcinoma Locally Advanced Or Metastatic Cholangiocarcinoma Who Have Been Previous
Alecensa Is Indicated For The Treatment Of Patients With Anaplastic Lymphoma Kinase (Alk)-Positive Metastatic Non-Small Cell Lung Cancer (Mnsclc) As Detected By An Fda- Approved Test.
Tecentriq Is A Programmed Death-Ligand 1 (Pd-L1) Blocking Antibody